SEC Form 4Coverage since Jun 8, 2026
$INDV insider trading
Over the last 12 months, Indivior Pharmaceuticals insiders reported 1 buy totaling $54K and 3 sales totaling $2.8M across SEC Form 4 filings. 75% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $54K 1 event
- Sold · 12m
- $2.8M 3 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 75% pre-arranged plans
Side
Price · $INDV · 12Mvia TradingView
Top insiders · 12m
Heidbreder ChristianChief Scientific Officer2× · $1.5M
Anderson Woodrow DChief Accounting Officer1× · $54K
Preblick RyanChief Financial Officer1× · $1.4M
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Anderson Woodrow DChief Accounting Officer · O | ▲ Buy | 1,500 | $36.28 | $54K | +6.1% | — |
| Jul 10, 2026 | Heidbreder ChristianChief Scientific Officer · O | ▼ Sale | 18,586 | $41.14 | $765K | -8.2% | plan |
| Jun 11, 2026 | Heidbreder ChristianChief Scientific Officer · O | ▼ Sale | 18,586 | $38.06 | $707K | -7.5% | plan |
| Jun 8, 2026 | Preblick RyanChief Financial Officer · O | ▼ Sale | 36,000 | $37.7 | $1.4M | -11.2% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $INDV feed.